EVIDENCE FOR NEW METABOLIC PATHWAYS OF CHLORAMPHENICOL IN THE DUCK

被引:0
|
作者
CRAVEDI, JP
BARADAT, M
DEBRAUWER, L
ALARY, J
TULLIEZ, J
BORIES, G
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Following subcutaneous administration of [H-3]chloramphenicol (CP) to duck, HPLC and TLC analyses showed that the two most important metabolites in 0- to 24-hr excreta were CP-oxamic acid and CP-alcohol, which together accounted for about one-third of the radioactivity therein. The remainder was due to unchanged CP (15% dose), CP-base (5% dose), and various metabolites representing <4% dose each. Among these, CP-glucuronide and CP-sulfate have been previously isolated in mammals. In addition to these metabolites, several previously unreported in vivo CP biotransformation products were identified in this study by HPLC and MS comparison with synthetic reference compounds. These new metabolites were unequivocally identified as 1-O-monoacetyl CP, CP-1,3-diacetate, N-acetyl CP-base, CP-oxamylglycine, and CP-oxamylethanolamine. Besides these formally identified compounds, the CP-phosphate structure was tentatively assigned to a conjugate metabolite resistant to beta-glucuronidase and sulfatase hydrolysis. The possible origin of these metabolites is discussed extensively.
引用
收藏
页码:578 / 583
页数:6
相关论文
共 50 条
  • [1] INHIBITION OF MICROSOMAL DRUG METABOLIC PATHWAYS BY CHLORAMPHENICOL
    DIXON, RL
    FOUTS, JR
    BIOCHEMICAL PHARMACOLOGY, 1962, 11 (AUG) : 715 - &
  • [2] Adjustments in the diving time budgets of tufted duck and pochard: Is there evidence for a mix of metabolic pathways?
    Carbone, C
    DeLeeuw, JJ
    Houston, AI
    ANIMAL BEHAVIOUR, 1996, 51 : 1257 - 1268
  • [3] NEW ASPECTS OF METABOLIC CONJUGATION OF CHLORAMPHENICOL
    WAL, JM
    PELERAN, JC
    PERDU, E
    RAO, D
    BORIES, G
    DRUG METABOLISM AND DISPOSITION, 1988, 16 (04) : 635 - 639
  • [4] In vitro metabolism study of buprenorphine: Evidence for new metabolic pathways
    Picard, N
    Cresteil, T
    Djebli, N
    Marquet, P
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (05) : 689 - 695
  • [5] ANEMIA PRODUCED BY CHLORAMPHENICOL (CHLOROMYCETIN) IN THE DUCK
    RIGDON, RH
    CRASS, G
    MARTIN, N
    AMA ARCHIVES OF PATHOLOGY, 1954, 58 (01): : 85 - 93
  • [6] New metabolic pathways of α-lipoic acid
    Schupke, H
    Hempel, R
    Peter, G
    Hermann, R
    Wessel, K
    Engel, J
    Kronbach, T
    DRUG METABOLISM AND DISPOSITION, 2001, 29 (06) : 855 - 862
  • [7] STUDIES ON METABOLIC EFFECTS OF CHLORAMPHENICOL
    BANERJEE, S
    KUMAR, KS
    JOURNAL OF SCIENTIFIC & INDUSTRIAL RESEARCH, 1962, C 21 (10): : 269 - +
  • [8] METABOLIC EFFECTS AND TOXICITIES OF CHLORAMPHENICOL
    CLARK, CH
    MODERN VETERINARY PRACTICE, 1978, 59 (09): : 663 - 668
  • [9] New evidence for enrichment of metabolic, signaling, and inflammatory pathways in age-related macular degeneration
    Waksmunski, Andrea R.
    Bailey, Jessica Cooke
    Pericak-Vance, Margaret A.
    Scott, William K.
    Haines, Jonathan L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [10] \ Evidence for coordination of membrane trafficking and lipid metabolic pathways
    Gaspar, Maria L.
    Jesch, Stephen A.
    Brown, William J.
    Kohlwein, Sepp D.
    Henry, Susan A.
    CHEMISTRY AND PHYSICS OF LIPIDS, 2008, 154 : S33 - S33